Latest
Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence|Kanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer TherapiesKanvas Biosciences Raises $48M in Series A to Advance Microbiome-Based Cancer Therapies|Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026Woman Owned NYC and Pulse NYC Bring Women Leaders to the Center of AI Week New York 2026|SYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership ConversationsSYPartners and Pulse NYC Bring Radical Imagination Studio to #AIWeekNY for AI-Era Leadership Conversations|AI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product DesignAI Week NY: Magic EdTech’s UX Challenge Puts Trust at the Center of Product Design|Tessera Labs Raises $60M in Series A to Automate Enterprise System TransformationsTessera Labs Raises $60M in Series A to Automate Enterprise System Transformations|InstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account ActivationInstaSwitch Raises $4.7M in Seed Funding to Streamline Business Banking Account Activation|Scout Space Raises Up to $18M in Series A to Expand Space Domain Awareness InfrastructureScout Space Raises Up to $18M in Series A to Expand Space Domain Awareness Infrastructure|4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform4D Path Secures Strategic Financing to Advance Physics-Based Cancer Prediction Platform|Vastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance PlatformVastian Secures Strategic Investment from Bregal Sagemount to Expand Healthcare Compliance Platform|Altara Raises $7M in Seed Funding to Build AI Platform for Industrial Data IntelligenceAltara Raises $7M in Seed Funding to Build AI Platform for Industrial Data Intelligence
Back to articles

Apella Secures $80M in Series B Funding

There is a moment in every industry when the noise drops and the signal gets loud. Healthcare is in one of those moments, and Apella just turned the volume knob with an $80M Series B that feels less...

Startup FundingVenture CapitalSeries BData DrivenTech EcosystemStartup EcosystemHealthTechStartupsAIBiotechHealthcareDataTechnologyInnovation

There is a moment in every industry when the noise drops and the signal gets loud. Healthcare is in one of those moments, and Apella just turned the volume knob with an $80M Series B that feels less like a raise and more like a declaration. Founded in 2019 and based in San Francisco, Apella is doing the unglamorous work that actually moves the needle: making operating rooms run on truth instead of gut feel. Ambient AI, computer vision, and real-time operational intelligence quietly watching the room, learning the room, and giving hospitals back the rarest asset they have, which is time.

David Schummers, Cameron Marlow, and Jordan Tuttle did not stumble into this problem. David Schummers brings hard-earned perspective from Auris Health and years inside medical device companies where inefficiency shows up on the balance sheet and in patient outcomes. Cameron Marlow comes from building data science at Facebook and MIT Media Lab, which explains why Apella sees patterns humans miss and does not flinch. Jordan Tuttle spent decades in medical devices and biotech learning how hospitals actually buy, deploy, and scale technology when failure is not an option. Different paths, same obsession: remove friction without adding burden.

HighlandX led the round, and Corey Mulloy joining the board is not a ceremonial nod, it is an operational wager. Returning conviction from Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners says this story compounds. New capital from K2 HealthVentures, OpAmp Capital, and Houston Methodist tightens the loop between builder, buyer, and believer. When a nine-hospital system scales from a 36-room pilot to more than 200 operating rooms and then invests, that is not optimism, that is proof.

Apella has already supported 500,000 surgical cases. Hospitals using the platform are seeing a 5% increase in surgical volume without squeezing clinicians harder. The system detects operating room events with 99% accuracy in under one minute and predicts surgery duration 24% better than electronic health records. Tampa General Hospital is saving thousands of minutes every week and adding hundreds of procedures every year. This is not AI theater. This is math meeting muscle memory.

The Horizon module widens the lens, turning case duration, utilization, staffing, and capacity into something schedulers can trust. Expansion beyond operating rooms into interventional radiology, cardiology, and endoscopy is not ambition for headlines. It reflects a simple truth: procedures do not happen in isolation, and neither should the intelligence that runs them.

Healthcare is staring down an 11M worker shortage by 2030. You do not solve that with slogans. You solve it by making every room smarter, every minute accountable, and every clinician less buried in clicks. Apella is not trying to be loud. It is trying to be right. And right now, the signal is getting harder to ignore.